CASI Pharmaceuticals, Inc.
USD0.15
+0.00 (+3.08%)
CEO
David A. Cory
IPO Date
1996-06-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.15
Prev. Close
$0.15
Day Low
$0.15
Day High
$0.15
52W Low
$0.14
52W High
$3.09
Market Cap
$0.00B
Volume
0.01M
| -3.6 |
| 31 Dec 2022 | FY | 63.3% | -95.1% | -92.0% | -42.6% | 0.03 | 4.32 | -0.6 |
| 31 Dec 2021 | FY | 58.4% | -121.5% | -43.4% | -26.5% | 0.05 | 4.70 | -3.0 |
| 31 Dec 2020 | FY | 37.2% | -318.9% | -59.2% | -37.8% | 0.04 | 9.28 | -6.7 |
| 31 Dec 2019 | FY | 4.7% | -1098.1% | -62.1% | -44.2% | 0.03 | 7.74 | -6.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -25.1% | -24.2% | 0.01 | 23.89 | -12.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -27.9% | -23.9% | 0.04 | 8.65 | -18.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -45.5% | -34.1% | 0.07 | 20.86 | -6.8 |
| 31 Dec 2015 | FY | 86.9% | -15104.0% | 118.4% | -123.7% | -0.24 | 5.29 | -4.3 |
| -0.3 |
| 31 Mar 2025 | Q1 | 58.0% | -172.3% | 133.2% | -26.3% | -2.29 | 0.81 | -0.8 |
| 31 Dec 2024 | Q4 | 24.2% | -107.6% | -776.3% | -26.8% | 11.96 | 1.09 | -0.8 |
| 30 Sept 2024 | Q3 | 51.9% | -107.7% | -60.6% | -13.2% | 1.38 | 3.20 | -2.8 |
| 30 Jun 2024 | Q2 | 51.9% | -175.0% | -77.2% | -13.6% | 2.05 | 3.88 | -2.6 |
| 31 Mar 2024 | Q1 | 53.0% | -279.5% | -61.6% | -16.4% | 1.20 | 5.05 | -1.3 |
| 31 Dec 2023 | Q4 | 59.0% | -88.1% | -25.1% | -8.0% | 0.88 | 3.55 | -4.0 |
| 30 Sept 2023 | Q3 | 58.7% | -52.4% | -16.1% | -6.2% | 0.00 | 4.91 | -1.8 |
| 30 Jun 2023 | Q2 | 59.4% | -104.3% | -31.8% | -13.1% | 0.00 | 5.12 | -0.8 |